Insider

Clorox Co.

CLX Consumer Staples · 4 analyses · 7 expectations tracked

Clorox reported $1.9B in revenue (+33.3% YoY), compared with a +5.4% median across covered Consumer Staples peers. Insider tracks 7 open management expectations for this company. 1 open-market insider purchase recorded.

Mentioned in recent filings: Ukraine Russia Tariffs

What changed

Deals & ownership

Insider week: share purchases and sales by company executives

From October 31 to November 6, company executives and directors reported share transactions. This review covers market operations and plans to sell securities. Such disclosures are a technical requirement and do not allow for an assessment of insider sentiment or future company results.

What changed

Clorox first-quarter results: sales up 33.3%

In the first quarter of fiscal year 2027, The Clorox Company increased net sales to $1.9 billion, a 33.3% increase compared to the year-ago period. This result reflects the start of the fiscal year in a dynamic operating environment, significantly influenced by the integration of new businesses.

· Clorox Co.
What changed

Clorox names new CEO and updates compensation

The Clorox board of directors appointed Fabian Garcia as chief executive officer, effective January 5, 2027. Current CEO Linda Rendle will move to an advisory role until April 2, 2027, to ensure a smooth transition.

· Clorox Co.
What changed

Clorox reshapes business, begins search for new CEO

Clorox completed a five-year digital transformation, acquired GOJO Industries, and bought out the remaining interest in its Glad bags and wraps joint venture. Following these changes, CEO Linda Rendle decided to step down, prompting the board to launch a search for a new leader.

· Clorox Co.

Company history

October 2026

CLOROX CO /DE/: 12 recorded developments from 3 official sources in 2026-10.

  • 2026-10-07: The Clorox Company's Board of Directors recommends a vote FOR the ratification of the selection of Ernst & Young LLP as the company's independent registered public accounting firm. Source
  • 2026-10-07: The Clorox Company completed its U.S. Enterprise Resource Planning (ERP) system implementation, concluding a five-year digital transformation investment. Source
  • 2026-10-07: Clorox scheduled its Annual Meeting of Shareholders for Wednesday, November 18, 2026, at 9:00 a.m. Pacific Time. Source
  • 2026-10-07: The Clorox Company's Board of Directors recommends a vote FOR the election of ten director nominees: Gina Boswell, Stephen B. Bratspies, Pierre R. Breber, Julia Denman, Esther Lee, Stephanie Plaines, Linda Rendle, Matthew J. Shattock, Russell J. Weiner, and Christopher J. Williams. Source
  • 2026-10-29: The Board of Directors appointed Fabian Garcia as CEO and a member of the Board, effective January 5, 2027. Source
  • 2026-10-29: Matthew J. Shattock will receive an Independent Chair retainer of $225,000. Source
  • 2026-10-29: Fabian Garcia will receive an annual base salary of $100,000 and be eligible for an annual short-term incentive award with a target of $2,000,000. Source
  • 2026-10-29: Fabian Garcia will receive a one-time sign-on award of RSUs with a target value of $11,000,000. Source
  • 2026-10-29: Ms. Rendle's base salary of $1,350,000 will remain in effect during her advisory period. Source
  • 2026-10-29: Ms. Rendle's transition is considered a Retirement under the terms of her outstanding long-term incentive awards, which will vest according to their original terms. Source
  • 2026-10-29: Ms. Rendle will not receive additional long-term or incentive equity awards during the advisory period. Source
  • 2026-10-29: Mr. Garcia was appointed to serve as CEO, announced on October 29, 2026. Source

Monthly records are drafted by AI from each month’s checked filings and official sources (in English, as extracted), with every line linked to its source; storylines group related developments across analyses using vector embeddings (Amazon Titan Text Embeddings V2). Provisional context, not investment advice.

Key figures

From the 10-Q for the period ended September 30, 2026, filed November 2, 2026. SEC

LatestEarlierChange
Revenue quarter$1.9B$1.4B+33.3%
Net income quarter$170M$80M+112.5%
Diluted EPS quarter$1.39$0.65+113.8%
Dividends per share quarter$2.50$2.48+0.8%
Operating cash flow quarter$143M$93M+53.8%
Cash and cash equivalents balance$184M$143M+28.7%
Long-term debt balance$4B$4B0.0%

Next results expected around February 1, 2027 (estimate: the quarter ending about December 30, 2026 plus the 33 days the last report took). The company announces the actual date.

As the company tagged them in its filing (SEC XBRL). Quarter and year figures are compared with the same period a year earlier, balances with the previous balance sheet. Download CSV

Revenue by quarter, $B

1.8Q1 '251.7Q2 '251.7Q3 '252Q4 '25*1.4Q1 '261.7Q2 '261.7Q3 '261.9Q1 '27
Q4 = fiscal year minus the three quarters reported on their own. Revenue as the company tagged it in its SEC filings (XBRL). Guidance is the company's own, not our forecast.

Sector peers

How this company compares with 18 covered companies in Consumer Staples (median revenue change +5.4% YoY), from archived SEC XBRL filings.

CompanyLatest revenueRevenue YoYOperating margin
Clorox Co. CLX$1.9B+33.3%—
Costco Wholesale Corp COST$303B+10.1%3.9%
Walmart Inc. WMT$186B+5.9%5.0%
Kroger Co. KR$34.6B+2.0%2.8%
Target Corp TGT$26.5B+5.3%9.6%
Pepsico Inc PEP$25.3B+5.6%16.9%
Procter & Gamble Co PG$23.3B+4.0%25.5%

Latest reported period per company from SEC CompanyFacts (XBRL). Fiscal calendars differ across companies.

Expectations and reality

Open

  • The Company anticipates the operating environment will remain volatile and challenging in fiscal year 2027 as consumers may face greater pressure from continued macroeconomic uncertainty.

    Said November 2, 2026 · Period named: fiscal year 2027 · Source · Our article

    Not yet checked against later reports.

  • Fabian Garcia will begin his role as CEO and member of the Board on January 5, 2027.

    Said October 29, 2026 · Period named: January 5, 2027 · Source · Our article

    Not yet checked against later reports.

  • Linda Rendle will serve as a senior advisor to the Company through April 2, 2027.

    Said October 29, 2026 · Period named: April 2, 2027 · Source · Our article

    Not yet checked against later reports.

  • Ms. Rendle will serve the Company in an advisory capacity from the Effective Date through April 2, 2027.

    Said October 29, 2026 · Period named: through April 2, 2027 · Source · Our article

    Not yet checked against later reports.

  • Clorox intends to use a peer median salary, initially set at $1,250,000 and reviewed annually, to establish salaries for benefits and perquisites for senior executives.

    Said October 29, 2026 · Source · Our article

    Not yet checked against later reports.

  • Linda Rendle will serve in an advisory capacity through April 2, 2027.

    Said October 29, 2026 · Period named: April 2, 2027 · Source · Our article

    Not yet checked against later reports.

Show all (7)
  • The Board plans to engage an independent third-party facilitator to support its annual evaluation process for fiscal year 2027.

    Said October 7, 2026 · Period named: fiscal year 2027 · Source · Our article

    Not yet checked against later reports.

What management said to expect (targets, plans, forecasts) in the company's own documents (in English, as extracted), with the date and the period it named. Assessments are written by AI from the company's later reports: provisional, not checked by an editor, and a consistent later report is not proof. An editor's decision replaces them.

Governance events

Filings about how the company is run: auditor changes, restatements, leadership changes, late filings, delistings, Schedule 13D stakes and SEC comment letters, newest first.

DateEventFiling
October 29, 2026Director or officer departure or appointment (8-K item 5.02)8-K

As filed with the SEC, read by code. A comment letter is part of the SEC staff’s routine review and does not by itself mean a problem; item 5.02 covers appointments as well as departures; Form 25 may concern a bond or another class of securities.

Insider trades

DatePersonTradeSharesAvg. priceValueFiling
November 4, 2026Pierre R BreberPurchase4,000$100.06$400,251SEC

All insider trades →

Large funds (13F)

FundSharesValueChange in sharesQuarter
BlackRock8,121,560$657,927,575-19.1%Q3 2026
State Street7,723,356$625,669,070-8.4%Q3 2026
Two Sigma Investments3,674,615$297,680,561+6,658.0%Q3 2026
Geode Capital Management2,936,721$237,428,099-10.1%Q3 2026
Citadel Advisors1,909,772$154,710,630+8.2%Q3 2026
Norges Bank (Norway's sovereign fund)940,160$89,728,870—Q2 2026
Millennium Management994,306$80,548,729-52.0%Q3 2026
Fidelity (FMR)783,945$63,507,348+15.6%Q3 2026
D. E. Shaw & Co.47,261$3,828,614-59.0%Q3 2026
Renaissance Technologies28,200$2,284,482+2.2%Q3 2026
Bridgewater Associates7,320$592,993+4.5%Q3 2026
Wellington Management3,002$243,192-92.4%Q3 2026
T. Rowe Price178,077$14,427-0.5%Q3 2026

From the quarterly 13F-HR holdings reports of the large funds we follow, as filed. Funds file up to 45 days after the quarter ends, so positions may have changed since. Change: against the same fund's previous quarter. Not a recommendation.